GSK Slides After Buying Cancer Firm Tesaro For Hefty $5.1 bln GlaxoSmithKline has agreed to buy U.S. cancer specialist Tesaro for $5.1 billion, a costly investment to rebuild the pharmaceuticals business by new Chief...
